13F value (AUM)
$14.2B
A1
A16z Capital Management
A16Z CAPITAL MANAGEMENT, L.L.C.
$14.2B
13F long value · 2026-Q2Positions19
CategoryAsset Manager
Quarters tracked8
● #427 of 581 by 13F value
Size rank 3/10
2 NEW3 TRIM
Snapshot
A16z Capital Management's 13F portfolio at a glance — size, concentration and this quarter's activity.
Positions
19 (1 unmapped)
Top 19 weight
100.0%
Quarters tracked
8
Latest 13F filed
Aug 14, 2026
New positions
2
13F value by quarter
Total reported long value each quarter — fund flows plus market moves.
Top holdings — 2026-Q2
The fund's largest reported positions.
| Ticker | Issuer | Weight | Value | Shares | Since 2026-Q2 |
|---|---|---|---|---|---|
| SPCX | SPACE EXPLORATION TECHN CORP | 90.0% | $12.8B | 74.9M | — |
| NAVN | NAVAN INC | 4.5% | $645.4M | 28.2M | -30.4% |
| RVMD | REVOLUTION MEDICINES INC | 1.2% | $172.5M | 921.1K | -29.7% |
| META | META PLATFORMS INC | 0.8% | $119.7M | 212.5K | +30.2% |
| FIG | FIGMA INC | 0.8% | $108.2M | 6.0M | -4.3% |
| BIOA | BIOAGE LABS INC | 0.6% | $79.2M | 3.2M | -26.3% |
| XYZ | BLOCK INC | 0.5% | $77.3M | 1.0M | -6.2% |
| ERAS | ERASCA INC | 0.4% | $52.4M | 2.9M | +4.5% |
| MAZE | MAZE THERAPEUTICS INC | 0.4% | $50.8M | 1.7M | -11.3% |
| — | DAMORA THERAPEUTICS INC | 0.2% | $32.2M | 1.2M | — |
| OMDA | OMADA HEALTH INC | 0.2% | $25.3M | 1.2M | -32.9% |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 0.1% | $16.9M | 9.1M | +37.4% |
| RBLX | ROBLOX CORP | 0.1% | $14.9M | 274.6K | +5.8% |
| AKTS | AKTIS ONCOLOGY INC | 0.1% | $13.4M | 415.0K | -37.7% |
| CAMP | CAMP4 THERAPEUTICS CORP | 0.1% | $9.3M | 2.1M | +1.6% |
Quarterly changes — 2026-Q2
What A16z Capital Management opened, added, trimmed and exited this quarter, largest dollar moves first.
Conviction over time
Portfolio weight of the current top long holdings, quarter by quarter — rising weight = growing conviction.